Acadia Healthcare named Debra K. (“Debbie”) Osteen chief executive officer, effective immediately, and added her to the board. She succeeds Chris Hunter, who is departing the company and its board as Acadia finalizes a separation agreement. Board chair Reeve Waud said the transition is intended to optimize growth investments and portfolio performance amid sector headwinds, noting Osteen’s prior track record leading Acadia as CEO from 2018–2022 and her long tenure running UHS’s behavioral health division. Osteen said the company—now the largest stand-alone behavioral health provider in the U.S.—is positioned for long-term success through its network and JV partnerships. Acadia reaffirmed full-year 2025 guidance, projecting revenue of $3.28–$3.30B, adjusted EBITDA of $601–$611M, and adjusted EPS of $1.94–$2.04 (with standard non-GAAP caveats). The release also reiterates risk factors and notes ongoing evaluation of paths to enhance shareholder value.
CLICK HERE to read the full article.